Aier Eye Hospital's controlling shareholder releases 109 million shares from pledge, reducing the total pledged share ratio to 19.09%

MaticHoleFiller · 2026-03-21T15:06:01+00:00

Aier Eye Hospital Group announced that its controlling shareholder Aier Medical Investment completed the depletion of pledge on 109 million shares, reducing pledged shares to 611 million shares, with shareholding ratio decreased to 19.09%. This pledge depletion helps optimize the equity structure and enhance market confidence. The company emphasized that pledged shares face no liquidation risk.

MaticHoleFiller

2026-03-21 15:06:01

Abstract generation in progress

This newspaper report: Aier Eye Hospital Group Co., Ltd. (Stock code: 300015, referred to as “Aier Eye”) announced on March 16th that its controlling shareholder, Aier Medical Investment Group Co., Ltd. (referred to as “Aier Medical Investment”), has completed the release of some pledged shares, involving 109 million shares, accounting for 1.17% of the company’s total share capital.

The announcement shows that the pledged shares were released starting from December 21, 2020, with the release date on March 13, 2026. The pledgee is Shenzhen Ping An Huitong Investment Management Co., Ltd. After this release, the pledged shares held by Aier Medical Investment decreased from 721 million shares to 611 million shares, reducing its shareholding proportion from 22.51% to 19.09%.

As of the disclosure date, the pledge situation of Aier Medical Investment and its concerted actors (including actual controller Chen Bang) is as follows:

Shareholder Name	Number of Shares Held	Shareholding Ratio	Pledged Shares After This Release	Pledged Shares as a Percentage of Holdings	Percentage of Total Share Capital
Aier Medical Investment	3,202,323,587	34.34%	611,241,045	19.09%	6.55%
Chen Bang	1,443,791,891	15.48%	247,000,000	17.71%	2.65%
Total	4,646,115,478	49.82%	858,241,045	18.47%	9.20%

The announcement also states that among the 858 million pledged shares held by the controlling shareholder and its concerted actors, 100% are restricted or frozen, marked status, and among the unpledged shares, 69.84% are held by senior management with lock-up agreements. The company emphasizes that there is currently no risk of margin calls or forced liquidation on the pledged shares, and it will not have a substantial impact on the company’s operations or governance.

As a leading domestic ophthalmology medical service provider, Aier Eye has been consolidating its industry position through continuous expansion in recent years. The release of some pledged shares by the controlling shareholder helps optimize the company’s equity structure and further boost market confidence. The company states it will continue to monitor changes in shareholder pledges and strictly fulfill its information disclosure obligations.

Click to view the original announcement>>

Disclaimer: The market carries risks; investment should be cautious. This article is automatically published by an AI large model based on third-party databases and does not represent Sina Finance’s views. Any information appearing in this article is for reference only and does not constitute personal investment advice. Please refer to the actual announcement for any discrepancies. If you have questions, contact biz@staff.sina.com.cn.

Massive information, precise interpretation, all on Sina Finance App

Editor: Xiao Lang Kuai Bao

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.